BioLargo (BLGO) Competitors

Aemetis (NASDAQ:AMTX) and BioLargo (NASDAQ:BLGO) are both small-cap chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

Do institutionals & insiders believe in AMTX or BLGO?

27.0% of Aemetis shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 14.7% of Aemetis shares are held by insiders. Comparatively, 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the media favor AMTX or BLGO?

In the previous week, Aemetis had 7 more articles in the media than BioLargo. MarketBeat recorded 8 mentions for Aemetis and 1 mentions for BioLargo. Aemetis' average media sentiment score of -0.17 beat BioLargo's score of -0.33 indicating that Aemetis is being referred to more favorably in the media.

Company	Overall Sentiment
Aemetis	Neutral
BioLargo	Neutral

Do analysts recommend AMTX or BLGO?

Aemetis presently has a consensus target price of $17.00, indicating a potential upside of 541.51%. Given Aemetis' stronger consensus rating and higher possible upside, research analysts clearly believe Aemetis is more favorable than BioLargo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aemetis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
BioLargo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is AMTX or BLGO more profitable?

BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.70%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aemetis	-36.70%	N/A	-33.18%
BioLargo	-11.45%	-39.90%	-22.06%

Which has better valuation & earnings, AMTX or BLGO?

BioLargo has lower revenue, but higher earnings than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aemetis	$267.64M	0.63	-$87.54M	-$1.62	-1.64
BioLargo	$12.23M	4.63	-$3.50M	-$0.01	-18.41

Which has more risk and volatility, AMTX or BLGO?

Aemetis has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Summary

Aemetis beats BioLargo on 10 of the 16 factors compared between the two stocks.